SAB Biotherapeutics (SABS) Current Leases (2020 - 2026)
SAB Biotherapeutics' Current Leases was $160,000 in Q2 2026, up 8.0% from $148,156 a year earlier and up 1.9% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Current Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Current Leases at SAB Biotherapeutics came in at $154,000, up 8.0% from FY2024.
- Current Leases shows a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- In earlier years, Current Leases was $142,563 in FY2024 (+8.0%), $132,004 in FY2023 (-0.6%), $132,788 in FY2022 (-17.5%) and $161,050 in FY2021 (-17.3%).
- The Q2 2026 figure marks the highest quarterly Current Leases since Q4 2021.
- Compared with a year earlier, Current Leases has increased for ten straight quarters, with growth averaging 8.0% over the last eight quarters.
- The best year-over-year quarter for Current Leases over five years was Q4 2025 (growth of 8.0%); the worst was Q4 2022 (a decline of 17.5%).
- Per Business Quant data, SABS's Current Leases in the three quarters before Q2 2026 was $156,958 (Q1 2026), $154,000 (Q4 2025) and $151,033 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - | 163,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 163,000.00 |
| Jun 30, 2026 | 160,000.00 |
| Mar 31, 2026 | 156,958.00 |
| Dec 31, 2025 | 154,000.00 |
| Sep 30, 2025 | 151,033.00 |
| Jun 30, 2025 | 148,156.00 |
| Mar 31, 2025 | 145,333.00 |
| Dec 31, 2024 | 142,563.00 |
| Sep 30, 2024 | 139,847.00 |
| Jun 30, 2024 | 137,182.00 |
| Mar 31, 2024 | 134,568.00 |
| Dec 31, 2023 | 132,004.00 |
| Sep 30, 2023 | 129,489.00 |
| Jun 30, 2023 | 127,022.00 |
| Mar 31, 2023 | 132,816.00 |
| Dec 31, 2022 | 132,788.00 |
| Sep 30, 2022 | 140,891.00 |
| Jun 30, 2022 | 140,767.00 |
| Mar 31, 2022 | 145,898.00 |
| Dec 31, 2021 | 161,050.00 |
API Access
SAB Biotherapeutics Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();